Massachusetts General Hospital Cancer Centers

Boston, Massachusetts 02114

0 studies enrolling now · 1 studies all time

What they study most

Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive, Plasmablastic Lymphoma

Studies at this site

• Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma — Completed